Glanbia plc released its 2018 financials this week, revealing growing profits on the back of a few high-profile acquisitions. The nutritional ingredients and dairy business is dipping into the non-dairy sector and reorganizing its board of directors in...
Microbiome-based personalized food start-up Viome has entered into an agreement to buy fellow personalized nutrition company Habit from Campbell Soup Company.
South Korean organic produce distributor Ewha Company is planning to go international with its food brand Nature Food's signature red ginseng product, having China firmly in its sights.
The chief executive of Irish nutrition company Glanbia has revealed the firm has begun stockpiling supplies in the UK in the likely event of a no-deal Brexit.
The Irish government is to move ahead with plans to tax food supplements such as probiotics and Omega 3 fatty acids on the 1st March with the publication of guidance on the impending changes.
Pfizer and GlaxoSmithKline are merging their consumer health units, bringing the two pharma giants’ dietary supplement and over-the-counter brands into what analysts are calling “the world’s largest consumer health company.”
US nutrition data firm Medtronic is to acquire Nutrino Health in a deal that combines both firms’ expertise in nutritional intervention to address the threat of metabolic conditions such as diabetes.
Proposed plans could see food supplements such as probiotics and Omega 3 fatty acids subject to a VAT rate of up to 23% in moves set out by the Irish government in time for January next year.
Science in Sport (SiS) has revealed plans to acquire fellow sports nutrition firm PhD Nutrition in a €36.8m (£32m) deal, with the majority financed by a share offering subject to conditions.
French microbiome biotechnology firm Enterome has signed a global licensing, co-development and co-promotion agreement with major pharmaceutical player Takeda.
Royal DSM has announced plans to expand vitamin B2 production capacity at its facility in Grenzach, Germany, in a move intended to meet rising demand across the food and dietary supplement markets.
Aspen Pharmacare Holdings Limited, a global pharmaceutical company based in South Africa, has announced today, in conjunction with the announcement of its annual results for the year ended June 30, 2018, that it has concluded an agreement to divest of...
The UK Government’s clampdown on rogue health supplement firms scored a victory in the High Court as a company was ordered into liquidation after taking advantage of elderly and vulnerable customers.
Belgian flavour and ingredient firm Frutarom Health is targeting APAC expansion with its cosmeceutical products, starting with its most recent launch, PhytoflORAL.
Health and Happiness (H&H) achieved a revenue of RMB4573.6m (about US$669m) in the first half of 2018, which is 28.8% higher than the same period last year.
Are there reasons for sports nutrition firms to panic over Brexit? How likely will a trade deal be agreed that avoids tariffs and bureaucracy? And how can firms prepare for a new market and policy environment?
DSM has appointed Salutivia as UK distributor for its range of vitamins, carotenoids, and essential fatty acids in a deal that plays to Salutivia’s strengths in the supplement and food ingredient markets.
US-based Archer Daniels Midland (ADM) has completed its acquisition of UK-based Probiotics International Limited - known under its umbrella brand Protexin.
Riding on the ‘clean label’ sports nutrition movement, beverage giant Coca-Cola announced that it is acquiring a minority stake in BodyArmor, structured to lead to a full acquisition.
UK-based nutritional ingredient supplier Cambridge Commodities limited (CCL) has acquired the ingredient business of US-based raw and organic superfood wholesaler, Earth Circle Organics.
French-based biotech start-up Nextbiotix has successfully raised €7m in a Series A financing round, to develop microbiome-based approaches that address inflammatory bowel disease (IBD).
Health & Happiness International (H&H, formerly Biostime International) — and owner of Swisse — has announced it is seeking a loan of up to US$350m through Goldman Sachs.
LabCorp announced today that it has entered a definitive agreement to sell its Covance Food Solutions business to Eurofins Scientific for $670 million.
A change to how initiatives that tackle malnutrition are funded is overdue after a paper reveals an additional €19bn ($23.25bn) is needed each year until 2030 to meet Sustainable Development Goals (SDGs).
Novartis will sell its stake in a consumer healthcare joint venture to partner GSK and plans to invest the $13bn into its core pharmaceutical businesses.
Chinese investment into Australian health firms, including supplement manufacturers, will continue to grow as the country's healthcare system matures and the population ages, analysts from KPMG are forecasting.
Multiple reports peg Nestlé as the front runner to buy Merck KGaA’s consumer health unit in a race that could result in a deal worth up to $5 billion (€4.1bn).
Global nutritional ingredients player DSM has acquired BioCare Copenhagen A/S in a deal that will see it expand its probiotic and gut health portfolio.
This year was a year of big M&A announcements. In case you missed it, we've compiled a short round-up of some major merges and acquisitions relevant to the dietary supplement industry:
From cognitive health to healthy ageing, and probiotics to immunity, 2017 saw suppliers targeting Asia-Pacific's key growth sectors with a raft of new products and insights.
After successfully completing a Series B financing, Microbiome Therapeutics is gearing up for the launch of a ‘microbiome modulator’ product designed to help balance the microbiome and support healthy metabolism.
Ingredient giant DowDuPont announced that it has completed the Health & Nutrition arm of FMC Corporation—other than its omega-3 business—to build on the former’s “sustainable, bio-based food ingredients” market share.
Israeli flavour and fine ingredients firm Frutarom are now the owners of nutritional ingredients specialists Enzymotec in a €144m ($168m) deal for the remaining 81% of company shares.
Pfizer announced that it is “reviewing strategic alternatives” for its Consumer Healthcare business, the parent company of many iconic over-the-counter (OTC) brands from dietary supplements to personal care.
Technological advances are having a big impact on the APAC supplement and functional food industry, with the most innovative firms enjoying "a major boon” as more consumers go online for advice and to make purchases.
Supplement and food firms operating in China’s booming cross border e-commerce market have been buoyed by a year-long extension of the existing trade laws, which were due to be replaced on January 1.
The formation of a new company aims to ‘bring an external eye inside health and nutrition projects,’ with its founders looking to bring a new model of project management to the industry.
DSM has placed second on Fortune Magazine’s third annual Change the World list, which this year recognises 56 companies that have had a positive social impact through activities that are part of their core business strategies.
Unilever has made fostering relationships with start-up companies “a strategic imperative” as it works to leverage collaborations in order to meet evolving consumer needs.
Prinsen Food Group is set to buy Gustav Berning in a deal that will see the two merge to become one of the largest manufacturers of private label and branded active nutrition products in Europe.
French dairy giant Danone has become the latest European target of activist investors, with New York hedge fund Corvex Management taking a €340m stake in the group.
The European Commission (EC) has conditionally cleared a two-way deal acquisition between FMC and DuPont, based on promises that both companies will divest parts of their existing business.
Investment interest in the dietary supplement industry remains high, with the latest news being the sale of majority control of The Nature’s Bounty Co. to private equity firm KKR.
